A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

July 31, 2007

Conditions
Congestive Heart Failure
Interventions
DRUG

Piboserod

Trial Locations (17)

1530

Østlandske Hjertesenter, Moss

2000

Frederiksberg Hospital, Frederiksberg

2100

Rigshospitalet, Copenhagen

2300

Amager Hospital, Copenhagen

2400

Bispebjerg Hospital, Copenhagen

2650

Hvidovre Hospital, Hvidovre

2730

Amtsygehuset i Herlev, Herlev

5000

Odense Universitets Hospital, Odense

5221

Fana Hjertesenter, Nesttun

5700

Svendborg Sygehus, Svendborg

7006

St. Olavs Hospital, Trondheim

0027

Rikshospitalet, Oslo

0407

Ullevål Universitetssykehus, Oslo

Unknown

Stavanger Universitetssjukehus, Stavanger

HU16 5JQ

Castel Hill Hospital, Cottingham

YO16 4QP

Bridlington and District General Hospital, Bridlington

G11 6NT

Western Infirmary, Glasgow

All Listed Sponsors
collaborator

Smerud Medical Research International AS

OTHER

lead

Bio-Medisinsk Innovasjon

INDUSTRY

NCT00421746 - A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure | Biotech Hunter | Biotech Hunter